Skip to content
StockMarketAgent
Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

SHE/000403 stock hub

SHE/000403 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

SHE/000403is not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
11.1B
Shenzhen Stock Exchange
Market data

Live price

Current market quote for this ticker.

Current price
SHE/000403
In the news

Latest news · SHE/000403

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E11
P25 17.1P50 24.2P75 37.8
Trailing P/E32.9
P25 23.5P50 41.3P75 83.2
ROE4.4
P25 -0.9P50 4.1P75 8.8
ROIC5.1
P25 -0.5P50 5P75 11.4
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All SHE/000403 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
222
Groups with data
11
Currency
CNY
Showing 222 of 222 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

20
MetricValue
Country
China
Country code
CN
Employees
2,755
Employees Change
120%
Employees Change Percent
4.55
Enterprise value
CNY 11.2B
Exchange
Shenzhen Stock Exchange
Financial currency
CNY
First seen
2026-05-10
Industry
Biotechnology
Isin
CNE000000F14
Last refreshed
2026-05-10
Market cap
CNY 11.1B
Price
CNY 11.71
Price currency
CNY
Rev Per Employee
944,057x
Sector
Healthcare
Sic
2836
Symbol
she/000403
Website
https://www.slbiop.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

14
MetricValue
Earnings Yield
3.17%
EV Earnings
31.74x
EV/EBIT
22.94x
EV/EBITDA
17.86x
EV/FCF
-20.57x
EV/Sales
4.31x
FCF yield
-4.9%
Forward P/E
11.03x
P/B ratio
1.37x
P/E ratio
32.91x
P/S ratio
4.28x
PE Ratio10 Y
89.46x
PE Ratio3 Y
27.34x
PE Ratio5 Y
33.49x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

25
MetricValue
EBIT Margin
18.79%
EBITDA Margin
23.94%
Gross margin
39.54%
Gross Profit
CNY 1B
Gross Profit Growth
-18.32%
Gross Profit Growth Q
-33.68%
Gross Profit Growth3 Y
-3.71%
Gross Profit Growth5 Y
13.66%
Net Income
CNY 353.1M
Net Income Growth
-50.43%
Net Income Growth Q
-74.22%
Net Income Growth Years
0%
Net Income Growth3 Y
-13.09%
Net Income Growth5 Y
10.19%
Pretax Margin
16.38%
Profit Margin
13.58%
Profit Per Employee
CNY 128,184
Profitable Years
19
ROA
3.29
Roa5y
5.02
ROCE
5.87
ROE
4.39
Roe5y
8.63
ROIC
5.05
Roic5y
9.4

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

17
MetricValue
Cagr10y
-0.68%
Cagr1y
-30.43%
Cagr3y
-10.1%
Cagr5y
-15.37%
Div CAGR10
20.94%
Div CAGR3
143.13%
Div CAGR5
46.27%
EPS Growth
-51.56
EPS Growth Q
-77.78
EPS Growth Years
0
EPS Growth3 Y
-14.33
EPS Growth5 Y
0.89
Revenue Growth
0.28x
Revenue Growth Q
-8.47x
Revenue Growth Years
0x
Revenue Growth3 Y
6.29x
Revenue Growth5 Y
18.26x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

21
MetricValue
Asset Turnover
CNY 0.28
Assets
CNY 9.4B
Cash
CNY 699.2M
Current Assets
CNY 3.6B
Current Liabilities
CNY 1.1B
Debt
CNY 787.1M
Debt EBITDA
CNY 1.25
Debt Equity
CNY 0.1
Debt FCF
CNY -1.44
Equity
CNY 8.1B
Interest Coverage
24.95
Liabilities
CNY 1.3B
Long Term Assets
CNY 5.8B
Long Term Liabilities
CNY 226.1M
Net Cash
CNY -87.9M
Net Cash By Market Cap
CNY -0.79
Net Debt EBITDA
CNY 0.14
Net Debt Equity
CNY 0.01
Tangible Book Value
CNY 5.4B
Tangible Book Value Per Share
CNY 5.67
WACC
6.21

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
3.37
Inventory Turnover
0.97
Net Working Capital
CNY 2.4B
Quick ratio
1.59
Working Capital
CNY 2.5B
Working Capital Turnover
CNY 1.01

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

9
MetricValue
Buyback Yield
-2.33%
Dividend Growth
0%
Dividend Growth Years
3%
Dividend per share
CNY 0.35
Dividend Years
4
Dividend Yield
2.99%
Ex Div Date
2025-06-04
Last Dividend
CNY 0.35
Payout Ratio
77.72%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

37
MetricValue
10Y total return
-6.57%
1Y total return
-30.41%
200-day SMA
15.29
3Y total return
-27.35%
50-day SMA
13.21
50-day SMA vs 200-day SMA
50under200
5Y total return
-56.59%
All Time High
38.7
All Time High Change
-69.74%
All Time High Date
2020-08-04
All Time Low
5.65
All Time Low Change
107.29%
All Time Low Date
2013-06-26
ATR
0.27
Beta
0.41
Beta1y
0.12
Beta2y
0.1
Ch YTD
-14.46
High
11.84
High52
19.13
High52 Date
2025-08-08
High52ch
-38.79%
Low
11.65
Low52
11.56
Low52 Date
2026-05-07
Low52ch
1.3%
Ma50ch
-11.32%
Price vs 200-day SMA
-23.4%
RSI
25.82
RSI Monthly
29.97
RSI Weekly
24.95
Sharpe ratio
-1.74x
Sortino ratio
-2.27
Total Return
0.66%
Tr YTD
-14.46
Tr1m
-7.72%
Tr3m
-14.02%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

6
MetricValue
Operating Income
CNY 488.7M
Operating Income Growth
-35.58
Operating Income Growth Q
-78.31
Operating Income Growth3 Y
-2.56
Operating Income Growth5 Y
14.96
Operating margin
18.79

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

7
MetricValue
Float
532,453,529%
Net Borrowing
127,412,010
Shares Insiders
2.84%
Shares Institutions
13.71%
Shares Out
950,397,386
Shares Qo Q
15.81%
Shares Yo Y
2.33%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

60
MetricValue
Adjusted FCF
CNY -544.8M
Average Volume
7,323,417.45x
Bv Per Share
8.53
CAPEX
CNY -272.8M
Ch10y
-10.12
Ch1m
-7.72
Ch1y
-31.49
Ch3m
-14.02
Ch3y
-29.82
Ch5y
-58.17
Ch6m
-27.04
Change
0.26%
Change From Open
0.43
Close
11.68
Days Gap
-0.17
Depreciation Amortization
133,994,989
Dollar Volume
96,012,081.6
Earnings Date
2026-04-29
EBIT
CNY 488.7M
EBITDA
CNY 622.7M
EPS
CNY 0.36
F Score
3
FCF
CNY -544.8M
FCF EV Yield
-4.86x
FCF Per Share
CNY -0.57
Financing CF
-146,634,546
Fiscal Year End
December
Founded
1,993
Goodwill
2,536,010,097
Graham Number
8.26576
Graham Upside
-29.41
Income Tax
CNY 72.7M
Investing CF
187,664,624
Is Primary Listing
1
Last Earnings Date
2026-04-29
Last Report Date
2026-03-31
Last Split Date
2025-06-04
Last Split Type
Forward
Lynch Fair Value
CNY 3.63
Lynch Upside
-69.03
Ma150
14.38
Ma150ch
-18.57%
Ma20
12.51
Ma20ch
-6.42%
Net CF
-230,952,225
Next Earnings Date
2026-08-21
Open
11.66
Payment Date
2025-06-04
Position In Range
31.58
Ppne
2,046,493,000
Price Date
2026-05-08
Price EBITDA
CNY 17.87
Ptbv Ratio
2.07
Relative Volume
1.16x
Revenue
2,600,877,036x
Tax By Revenue
2.79x
Tax Rate
17.06%
Tr6m
-27.04%
Volume
8,199,153
Z Score
8.37
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

SHE/000403 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield
+3.0%
$0.35 annual per share
Payout ratio
+77.7%
Share of earnings returned as dividends. Below 60% is generally sustainable.
5Y dividend CAGR
+46.3%
3 consecutive years of growth
Total shareholder yield
+0.7%
Next ex-dividend date: 2025-06-04
Performance

SHE/000403 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
-30.4%
S&P 500 1Y: n/a
3Y total return
-27.4%
S&P 500 3Y: n/a
5Y total return
-56.6%
S&P 500 5Y: n/a
10Y total return
-6.6%
S&P 500 10Y: n/a
Ownership

Who owns SHE/000403?

Insider, institutional, and short-interest positioning.

Institutional ownership
+13.7%
Share of float held by funds and institutions
Insider ownership
+2.8%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
+2.3%
Negative means the company is buying back shares.
Technical

SHE/000403 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
25.8
Below 30: short-term oversold
Price vs 200-day MA
-23.4%
50/200-day relationship not available
Beta (5Y)
0.41
Less volatile than the market
Sharpe ratio
-1.74
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About SHE/000403

Hub-level FAQ points readers to the deeper analysis pages.

What is the current she/000403 stock rating?

she/000403 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full she/000403 analysis?

The full report lives at /stocks/she/000403/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for she/000403?

The latest report frames she/000403 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the she/000403 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.

she/000403 stock profile: metrics, valuation and analysis | Stock Market Agent AI